Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protracted Temozolomide in Recurrent High-Grade Glioma
NCT00575887Phase 2Completed
- Sponsor
- Marmara University
- Start
- Aug 2006
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide in high-grade glioma (HGG), sponsored by Marmara University. Started Aug 2006; status: completed.
02
Drugs
temozolomide
03
Conditions
high-grade glioma (HGG)
Beyond the preview
Go deeper on NCT00575887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00575887.